Log in to save to my catalogue

Intracerebroventricular administration of oxytocin and intranasal administration of the oxytocin der...

Intracerebroventricular administration of oxytocin and intranasal administration of the oxytocin der...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ff4dd2c485744413a1596cf3f380bc36

Intracerebroventricular administration of oxytocin and intranasal administration of the oxytocin derivative improve β‐amyloid peptide (25–35)‐induced memory impairment in mice

About this item

Full title

Intracerebroventricular administration of oxytocin and intranasal administration of the oxytocin derivative improve β‐amyloid peptide (25–35)‐induced memory impairment in mice

Publisher

United States: John Wiley & Sons, Inc

Journal title

Neuropsychopharmacology reports, 2022-12, Vol.42 (4), p.492-501

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Aim
We previously reported that oxytocin, a peptide hormone, can reverse the β‐amyloid peptide (25–35) (Aβ25–35)‐induced impairments of the murine hippocampal synaptic plasticity. In this study, we examined the effects of oxytocin on the Aβ25–35‐induced impairment of cognitive behavior in murine in order to investigate the potential of oxytocin...

Alternative Titles

Full title

Intracerebroventricular administration of oxytocin and intranasal administration of the oxytocin derivative improve β‐amyloid peptide (25–35)‐induced memory impairment in mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ff4dd2c485744413a1596cf3f380bc36

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ff4dd2c485744413a1596cf3f380bc36

Other Identifiers

ISSN

2574-173X

E-ISSN

2574-173X

DOI

10.1002/npr2.12292

How to access this item